Pharmaceutical Intermediates Market (By Product: Chemical Intermediates, Bulk Drug Intermediates, Custom Intermediates; By Application: Analgesics, Ant-inflammatory Drug, Cardiovascular Drugs, Anti-Diabetic Drugs, Anti-Cancer Drugs, Others; End User: Biotech & Pharma Companies, Research Laboratory, CMO/CRO) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Frequently Asked Questions

The global pharmaceutical intermediates market size was reached at USD 33.63 billion in 2023 and it is projected to hit around USD 54.78 billion by 2033.

The global pharmaceutical intermediates market is growing at a compound annual growth rate (CAGR) of 5% from 2024 to 2033.

The North America region has accounted for the largest pharmaceutical intermediates market share in 2023.

The leading companies operating in the pharmaceutical intermediates market are BASF SE, Aceto Corporation, Sanofi SAIS, Chiracon GmbH, Yin-sheng Bio-tech Co. Ltd., Dishman Group, Green Vision Life Sciences, Midas Pharma GmbH, Vertellus Holdings LLC. and Lonza Group.

Report Details

  • Report Code:38525
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:September 2024
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033
  • Download Sample

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert